Prevalence of lower-extremity amputation among patients with diabetes mellitus: Is height a factor? (2024)

Abstract

Taller patients with diabetes mellitus have been shown to be more susceptible than shorter diabetic patients to peripheral sensory loss.^{1,2,3,4,5,6,7} This greater susceptibility could be due to increased vulnerability of longer nerve fibres to damage from external trauma or from the micro-or macrovascular complications of diabetes. Because peripheral sensory loss with the development of foot ulcers is the most common indication for lower-extremity amputation among diabetic patients,⁸ taller patients may be at increased risk of such a procedure. In Taiwan, although diabetes mellitus accounts for a third⁹ to half¹⁰ of all lower-extremity amputations, the procedure is much less common among Taiwanese people of shorter stature than among white people who are much taller.¹⁰ Similarly low procedure rates have been observed in other Asian populations.¹⁰ The reason for the difference in rates between ethnic groups is unknown, but height may be a factor.

The objectives of this study were to determine the prevalence of lower-extremity amputation among patients with diabetes mellitus (type 1 and type 2) and to evaluate the association between height and lower-extremity amputation, with adjustment for the potential confounding effects of age, sex, duration of diabetes, smoking status, hypertension, fasting plasma glucose level and dyslipidemia.

Methods

The study design was approved and supported by an ad hoc ethics committee of the Department of Health of Taiwan.

Because more than 96% of Taiwan residents (except for those who are involved in military service or are incarcerated) are covered by the compulsory National Health Insurance (NHI) plan, introduced in March 1995, and because the copayment rate is low (5%–30% for inpatient care and a fixed charge of about US$1.40–$12.4 for outpatient care), almost all diabetic patients are seen by NHI physicians.^11,12 Taiwan is a small island, and hospitals are easily accessible by people in all parts of the island. Because patients do not need a referral to visit a doctor in a hospital and because hospitals provide better facilities and services than primary care physicians, most diabetic patients in Taiwan are cared for at hospitals. On average, a patient with diabetes visits an outpatient clinic 35.8 times a year.¹³ Reasons for these visits include getting prescriptions, dental care, eye examinations, physiotherapy, chiropractic care, acupuncture, and other medical consultations and procedures.

The databases of 66 hospitals and clinics located in every region of Taiwan were used to identify all patients seen in these institutions between 1995 and 1998 with a diagnosis of diabetes mellitus. The sample is described in detail elsewhere.^11,12 Of the 256 036 patients identified, a sample of 128 572 was randomly chosen, with the expectation that 70% would complete the telephone interviews.

Between Mar. 1, 1995, and Apr. 30, 2002, trained interviewers administered the survey by telephone using a structured questionnaire; they made up to 3 attempts to reach subjects before excluding them from the study. To obtain as much information as possible and to keep missing data to a minimum, the interviewers handed the questionnaires in every week, and all returned questionnaires were checked for internal consistency by an assistant and then checked again by me. For questionnaires that had excessive amounts of missing data, the interviewers were asked to go back to the patients for more information.

The information obtained during the interview included demographic data; self-reported height and weight; ethnic background of both parents (respondents were asked to choose from 5 categories [f*ckien, Hakka, Mainlander, Aborigine or other]); history of lower-extremity amputation; initial symptoms or clinical events that led to the diagnosis of diabetes; current treatment of diabetes; history of smoking; hypertension; family history of diabetes and hypertension; and use of betel nut (to evaluate health problems associated with betel-nut chewing).

A subset of the study population who reported having visited an NHI physician in the month before the interview were asked whether they had dyslipidemia and, if so, whether they had received treatment for it; they were also asked for the results of any fasting plasma glucose level obtained in the 3 months before the interview (the longest duration for which insulin and other drugs can be prescribed within the NHI).

Lower-extremity amputation was defined by a history of surgical resection of a part of the lower extremity on either side. Trauma-related amputations were not included. Type 1 diabetes was defined on the basis of one of the following criteria: diabetic ketoacidosis at the onset of diabetes mellitus, or the need for insulin injection within 1 year after the diagnosis of diabetes. If the patient did not have type 1 diabetes, he or she was considered to have type 2 diabetes. Hypertension was defined by a self-reported history and by a reported systolic blood pressure of 140 mm Hg or greater, a diastolic pressure of 90 mm Hg or greater, or both. For smoking status, patients were classified as never smokers, ex-smokers or current smokers.

Another interview, by someone other than the initial interviewer, was completed with 728 patients from a random sample of 1000 patients within 12 months after the first interview. Of the patients who were interviewed twice, 7 were consistent in reporting a lower-extremity amputation at both interviews; 1 patient reported undergoing the procedure between the first and second interviews. Inter-interviewer reliability was determined by correlation coefficients for the continuous variables (age at onset of diabetes, height, and systolic and diastolic blood pressures) and by percent agreement for the categorical variables (smoking status and hypertension). The correlation coefficients for the 2 interviewers for the continuous variables were 0.972, 0.904, 0.626 and 0.436, respectively (p < 0.01 for all); the percent agreement for the categorical variables was 91.7% and 97.7%, respectively.

Data are expressed as means (and standard deviations) or percentages, and p values below 0.05 were considered statistically significant. Age was categorized into 3 groups (< 55, 55–64 and ≥ 65 years); the age-and sex-specific prevalences of lower-extremity amputation were calculated for type 1 and type 2 diabetes. The χ² test was used to test differences in prevalence between sex and age groups.

Height was categorized into quartiles. Actual and adjusted prevalences of lower-extremity amputations were calculated for each quartile. Actual prevalences were tested by the linear test for trend. Covariates used to estimate the adjusted prevalences were age, sex, type of diabetes, duration of diabetes, smoking status and hypertension.¹⁴

Logistic regression analyses were used to estimate the odds ratios and 95% confidence intervals for lower-extremity amputation for the various risk factors. Two models were created: the first was for all of the study subjects and adjusted for age, sex, type of diabetes, duration of diabetes, smoking status, hypertension and height. The second model was for the subgroup of patients who reported their fasting plasma glucose level and dyslipidemia status; these 2 factors were entered into the model in addition to the variables used in the first model.

Results

Of the 128 572 randomly selected subjects, 93 484 (72.7%) completed the telephone survey. The age and sex distribution of the respondents was comparable to that of the original cohort of 256 036 diabetic patients.^11,12 A total of 368 patients were excluded because they were less than 18 years old, which left 93 116 respondents; 9295 of them reported their fasting plasma glucose level and dyslipidemia status and were included in the subgroup analysis.

Table 1 shows the baseline characteristics of the respondents. A total of 784 patients (0.8%) reported a history of lower-extremity amputation. The age-and sex-specific prevalences of such amputation by type of diabetes are shown in Table 2. The prevalence increased significantly with age among men and women with type 2 diabetes, but a significant increase with age was evident only among women with type 1 diabetes. Among patients with type 2 diabetes, men were significantly more likely than women to have had a lower-extremity amputation in all age groups except the youngest (< 55 years).

Fig. 1 shows the actual and adjusted prevalences of lower-extremity amputation by height quartiles for all of the diabetic patients and for those with type 1 and type 2 diabetes. A significant increase in trends was observed (p < 0.05).

Fig. 2 shows the adjusted odds ratios for lower-extremity amputation among all of the subjects (model 1) and among the subgroup of respondents for whom data were available on fasting plasma glucose level and dyslipidemia (model 2). In the first model, all of the factors except for smoking status (current smoker) and sex were found to be significant (Fig. 2, top panel). In the subgroup analysis (model 2), height, duration of diabetes, smoking status (ex-smoker), hypertension and fasting plasma glucose level were significant factors (Fig. 2, bottom panel).

Interpretation

This study revealed a strong and statistically significant association between height and risk of lower-extremity amputation among diabetic patients. The association held even after adjustment for other risk factors for this type of amputation. Every additional 10 cm of height was associated with a 16% increase in the risk of amputation. In the subgroup analysis, in which adjustments were made for additional information on fasting plasma glucose level and dyslipidemia, the adjusted risk of amputation was even larger (79% for every additional 10 cm of height).

This study had several limitations. Sensory dysfunction could not be evaluated. Taller patients are known to be at increased risk of peripheral sensory loss compared with shorter patients.^{1,2,3,4,5,6,7} The association between height and lower-extremity amputation would be underestimated if taller patients who had undergone amputation were less healthy and had more comorbidities (e.g., compression of vertebral disc space) than shorter patients who had undergone amputation. The association between height and lower-extremity amputation was stronger in the subgroup analysis that adjusted for fasting plasma glucose level and dyslipidemia than in the main analysis that did not include these 2 factors. Because the data were collected over 7 years, a healthy survivor bias may have existed. If taller patients undergoing lower-extremity amputation are at lower risk of death than shorter patients undergoing such amputation, estimates of the effects of height on amputation might be overestimated. Follow-up of the cohort to determine the incidence of lower-extremity amputation would give a more assured answer.

The association between lower-extremity amputation and weight or body mass index (BMI) was not evaluated in this study because weight and BMI change significantly under different disease conditions and nutritional states and because the weight of lost limbs in amputated patients is difficult to estimate; height, on the other hand, changes minimally and will only decrease after puberty. The significant association between height and lower-extremity amputation persisted even after adjustments for weight and BMI (data not shown).

As in previous studies in Taiwan,^9,11,15 diabetic men were found to be at higher risk of lower-extremity amputation than their female counterparts (Table 2). However, in the present study, sex did not remain a significant factor after adjustment for the other confounding variables (Fig. 2). In fact, in another logistic regression analysis in which only sex and height were included as independent variables, only height was found to be significantly associated with lower-extremity amputation (data not shown). This observation suggests that the difference in amputation prevalence between the men and women was due to a confounding effect of height.

In conclusion, height is a risk factor for lower-extremity amputation among diabetic patients. This effect appears to be independent of other known risk factors. Although the underlying mechanism could not be identified, it may be wise to pay particular attention to the early detection and treatment of leg ulcers in taller patients with diabetes.

Acknowledgments

The author thanks the Department of Medical Research, National Taiwan University Hospital, for providing the facilities, space and support for the related studies.

Footnotes

REFERENCES